Compare OMH & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OMH | IINN |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | Singapore | Israel |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.6M | 35.3M |
| IPO Year | 2023 | 2021 |
| Metric | OMH | IINN |
|---|---|---|
| Price | $1.48 | $0.60 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 157.3K | ★ 1.4M |
| Earning Date | 11-28-2025 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $10,264,748.00 | $289,000.00 |
| Revenue This Year | $28.40 | N/A |
| Revenue Next Year | $23.07 | $9,715.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 78.86 | N/A |
| 52 Week Low | $0.59 | $0.40 |
| 52 Week High | $4.46 | $1.65 |
| Indicator | OMH | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 58.31 | 29.36 |
| Support Level | $1.17 | $0.61 |
| Resistance Level | $1.29 | $0.76 |
| Average True Range (ATR) | 0.20 | 0.08 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 56.96 | 9.69 |
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.